Eton Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $11,647 | $10,324 | $9,074 | $7,966 |
Gross Profit | 6,476 | 6,302 | 5,626 | 5,007 |
EBITDA | 984 | 509 | -2,656 | -548 |
EBIT | 629 | -2,935 | -800 | |
Net Income | -598 | 627 | -3,041 | -811 |
Net Change In Cash | 11,647 | 10,324 | 9,074 | 7,966 |
Free Cash Flow | -8,897 | 4,820 | 1,255 | -4,355 |
Cash | 14,936 | 20,261 | 17,694 | 16,655 |
Basic Shares | 26,136 | 26,550 | 25,778 | 25,763 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $39,011 | $31,642 | $21,251 | $21,832 |
Gross Profit | 23,411 | 21,061 | 14,318 | 19,209 |
EBITDA | -2,597 | -291 | -6,486 | -1,121 |
EBIT | -1,192 | -8,251 | -1,568 | |
Net Income | -3,823 | -936 | -9,782 | -2,961 |
Net Change In Cash | 39,011 | 31,642 | 21,251 | 21,832 |
Cost of Revenue | 1,899 | |||
Free Cash Flow | 943 | 6,040 | 2,033 | -7,980 |
Cash | 14,936 | 21,388 | 16,305 | 14,406 |
Basic Shares | 25,895 | 25,645 | 25,146 | 25,207 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.03 |
2024-09-30 | $0.02 |
2024-06-30 | -$0.12 |
2024-03-31 | -$0.03 |
